Daphne L. Taylor
Senior VP & CFOMs. Daphne L. Taylor, C.P.A., serves as Chief financial Officer of Aptevo Therapeutics Inc. since March 03, 2023 and serves as its Senior Vice President. She served as Senior Vice President of Finance at Aptevo Therapeutics Inc. since August 2022 until March 03, 2023. She served as the Chief Financial Officer and Vice President of Finance & Administration at BioLife Solutions, Inc. since August 17, 2011 until February 25, 2016 and served as its Secretary since January 30, 2013 until February 25, 2016. Ms. Taylor served as Principal Accounting Officer at BioLife Solutions, Inc. until February 25, 2016. She served as Corporate Controller of BioLife Solutions, Inc. since March 2011 until July 2011. She served as a Vice President and Corporate Controller of Cardiac Science Corporation from February 22, 2006 to January 2009 and served as its Chief Accounting Officer from February 22, 2005 to January 2009. Ms. Taylor was responsible for all activities of Cardiac Science's Accounting team. Previously, she served as a Vice President and Corporate Controller at Looksmart, Ltd. from October 2004 to November 2005, Corporate Controller from April 2003 to October 2004 and Assistant Controller from April 2002 to April 2003. She also held Corporate Controller positions at SpeedTrak Communications and ViroLogic and accounting positions at companies, including Core-Mark International from 1996 to 2000, Pacific Telesis Group and Coopers & Lybrand from 1991 to 1994. Ms. Taylor is a Certified Public Accountant and earned a Bachelor of Arts, Management and Accounting from Sonoma State University.
Positions
- Company NameAptevo Therapeutics Inc.Stock CodeAPVOPositionSenior VP & CFOColleagues
- MLMarvin L. WhiteExecutive Chair
- JGJeffrey G. LamotheCEO, President & Director
- SKSoYoung KwonCorporate Secretary, Senior VP, General Counsel, Business Development & Corporate Affairs
- MJMary J. JanatpourSenior VP & Chief Scientific Officer
- ZPZsolt P. HarsanyiIndependent Director
- BLBarbara Lopez KunzIndependent Director
- JEJohn E. NiederhuberLead Independent Director
